drugset / Trial / NCT05304130
A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the safety, tolerability and pharmacokinetics (PK) profiles of otilimab in healthy Japanese participants.
Timeline
- Start
- 2023-02-08
- Primary completion
- 2023-05-04
- Completion
- 2023-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Otilimab | Monoclonal antibody | — | — |